# Aditum Bio

Aditum Bio is a Private Equity based in Oakland, United States.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Oakland, United States
- **Region:** North America
- **Address:** Oakland, United States
- **Founded:** 2019
- **Assets under management:** Undisclosed
- **Website:** www.aditumbio.com
- **LinkedIn:** https://www.linkedin.com/company/aditum-bio

## Regulatory record

- **CRD number:** 305442
- **SEC file number:** 802-117529
- **Registration status:** Registered
- **Latest Form ADV filing:** 2026-03-31T05:00:00.000Z
- **Reports private funds:** Yes
- **Private funds reported:** 0
- **IAPD record:** https://adviserinfo.sec.gov/firm/summary/305442

## About

Aditum Bio is a biotech venture firm committed to improving health by accelerating drug development in disease areas with high unmet need where medical innovation can have a significant impact. Aditum Bio in-licenses promising drug candidates and spins out individual companies dedicated to bringing each candidate through early clinical trials. It fosters an incubator model, focusing on the translational phase of drug development.

## People

- Joe Jimenez — Co-Founder and Managing Director
- Josh Gertsman — Partner

## Related profiles

- [Adirondack Foundation](https://altss.com/profile/adirondack-foundation)
- [Aditum Investment Management](https://altss.com/profile/aditum-investment-management)

---

Last updated: 2026-08-11T15:05:57.154Z

Canonical page: https://altss.com/profile/aditum-bio

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology